The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S,5S)-2,5-diamino-6-((3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxydihydrofuran-2(3H)-ylidene)hexanoic acid ID: ALA4550297
PubChem CID: 101982305
Max Phase: Preclinical
Molecular Formula: C15H21N7O5
Molecular Weight: 379.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncnc2c1ncn2[C@@H]1O/C(=C\[C@@H](N)CC[C@H](N)C(=O)O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C15H21N7O5/c16-6(1-2-7(17)15(25)26)3-8-10(23)11(24)14(27-8)22-5-21-9-12(18)19-4-20-13(9)22/h3-7,10-11,14,23-24H,1-2,16-17H2,(H,25,26)(H2,18,19,20)/b8-3-/t6-,7-,10+,11+,14+/m0/s1
Standard InChI Key: YNKCTZQHSHSLNN-GHBFAAIGSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
17.5568 -4.1427 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7960 -4.3938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1759 -4.5817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8365 -3.3230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5423 -5.1295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1275 -3.8931 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.9007 -4.0441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2553 -5.4118 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6825 -3.3271 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7348 -5.1295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7889 -5.9069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4786 -4.3594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6378 -4.3706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0332 -5.7605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4690 -5.9028 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7146 -4.1166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7324 -5.2424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2918 -3.8894 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6947 -3.3133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3922 -2.8874 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9772 -2.9223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2798 -3.3482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5622 -2.9572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8648 -3.3831 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.5420 -2.1402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2395 -1.7143 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8245 -1.7492 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 1
1 3 1 0
1 4 1 0
5 2 1 0
2 6 1 0
3 7 2 0
3 8 1 0
4 9 2 0
5 10 1 0
5 11 1 6
6 12 1 0
7 13 1 0
8 14 2 0
10 15 1 6
12 16 2 0
13 17 2 0
13 18 1 0
16 19 1 0
7 9 1 0
10 12 1 0
14 17 1 0
19 20 1 6
19 21 1 0
21 22 1 0
22 23 1 0
23 24 1 6
23 25 1 0
25 26 2 0
25 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.38Molecular Weight (Monoisotopic): 379.1604AlogP: -1.94#Rotatable Bonds: 6Polar Surface Area: 208.65Molecular Species: ZWITTERIONHBA: 11HBD: 6#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 9#RO5 Violations (Lipinski): 2CX Acidic pKa: 1.60CX Basic pKa: 9.82CX LogP: -5.37CX LogD: -6.76Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.33Np Likeness Score: 0.98
References 1. Zhu K, Song JL, Tao HR, Cheng ZQ, Jiang CS, Zhang H.. (2018) Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors., 28 (23-24): [PMID:30366617 ] [10.1016/j.bmcl.2018.10.026 ]